RT Journal Article
SR Electronic
T1 The Prediction of Drug Metabolism, Tissue Distribution, and Bioavailability of 50 Structurally Diverse Compounds in Rat Using Mechanism-Based Absorption, Distribution, and Metabolism Prediction Tools
JF Drug Metabolism and Disposition
JO Drug Metab Dispos
FD American Society for Pharmacology and Experimental Therapeutics
SP 649
OP 659
DO 10.1124/dmd.106.014027
VO 35
IS 4
A1 Stefan S. De Buck
A1 Vikash K. Sinha
A1 Luca A. Fenu
A1 Ron A. Gilissen
A1 Claire E. Mackie
A1 Marjoleen J. Nijsen
YR 2007
UL http://dmd.aspetjournals.org/content/35/4/649.abstract
AB The aim of this study was to assess a physiologically based modeling approach for predicting drug metabolism, tissue distribution, and bioavailability in rat for a structurally diverse set of neutral and moderate-to-strong basic compounds (n = 50). Hepatic blood clearance (CLh) was projected using microsomal data and shown to be well predicted, irrespective of the type of hepatic extraction model (80% within 2-fold). Best predictions of CLh were obtained disregarding both plasma and microsomal protein binding, whereas strong bias was seen using either blood binding only or both plasma and microsomal protein binding. Two mechanistic tissue composition-based equations were evaluated for predicting volume of distribution (Vdss) and tissue-to-plasma partitioning (Ptp). A first approach, which accounted for ionic interactions with acidic phospholipids, resulted in accurate predictions of Vdss (80% within 2-fold). In contrast, a second approach, which disregarded ionic interactions, was a poor predictor of Vdss (60% within 2-fold). The first approach also yielded accurate predictions of Ptp in muscle, heart, and kidney (80% within 3-fold), whereas in lung, liver, and brain, predictions ranged from 47% to 62% within 3-fold. Using the second approach, Ptp prediction accuracy in muscle, heart, and kidney was on average 70% within 3-fold, and ranged from 24% to 54% in all other tissues. Combining all methods for predicting Vdss and CLh resulted in accurate predictions of the in vivo half-life (70% within 2-fold). Oral bioavailability was well predicted using CLh data and Gastroplus Software (80% within 2-fold). These results illustrate that physiologically based prediction tools can provide accurate predictions of rat pharmacokinetics. The American Society for Pharmacology and Experimental Therapeutics